T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSP
2251
BrightSpire Capital
BRSP
$628M
| $450K | ﹤0.01% |
59,589
+6,848
| +13% | +$58K |
|
|
DM
2252
DELISTED
Desktop Metal, Inc.
DM
| $450K | ﹤0.01% |
20,474
+841
| +4% | +$24.6K |
|
2253
Arcus Biosciences
RCUS
$3.67B
| $449K | ﹤0.01% |
17,701
-1,736
| -9% | -$42.5K |
|
2254
Delek US
DK
$4.12B
| $447K | ﹤0.01% |
17,317
+5,273
| +44% | +$142K |
|
|
AMWD
2255
DELISTED
American Woodmark
AMWD
| $446K | ﹤0.01% |
9,920
+1,253
| +14% | +$60.5K |
|
2256
Par Pacific Holdings
PARR
$4.12B
| $445K | ﹤0.01% |
28,525
+679
| +2% | +$10.7K |
|
2257
DMC Global
BOOM
$155M
| $444K | ﹤0.01% |
24,624
+139
| +0.6% | +$3.41K |
|
2258
Heritage Financial
HFWA
$1.22B
| $444K | ﹤0.01% |
17,633
+258
| +1% | +$6.44K |
|
2259
Vericel Corp
VCEL
$2.29B
| $442K | ﹤0.01% |
17,546
-2,307
| -12% | -$68.1K |
|
2260
Astec Industries
ASTE
$994M
| $441K | ﹤0.01% |
10,804
+218
| +2% | +$9.28K |
|
|
CVGW
2261
DELISTED
Calavo Growers
CVGW
| $441K | ﹤0.01% |
10,562
-619
| -6% | -$22.4K |
|
2262
RadNet
RDNT
$6.06B
| $441K | ﹤0.01% |
25,492
+465
| +2% | +$9.05K |
|
|
CYBE
2263
DELISTED
Cyberoptics Corp
CYBE
| $440K | ﹤0.01% |
12,585
-315
| -2% | -$12.9K |
|
2264
NVE Corp
NVEC
$591M
| $438K | ﹤0.01% |
9,400
+105
| +1% | +$5.1K |
|
2265
Enovix
ENVX
$966M
| $436K | ﹤0.01% |
55,977
+24,206
| +76% | +$228K |
|
2266
Photronics
PLAB
$1.97B
| $436K | ﹤0.01% |
22,364
-800
| -3% | -$14K |
|
2267
iShares Core S&P Small-Cap ETF
IJR
$113B
| $435K | ﹤0.01% |
4,703
| – | – |
|
2268
Mastech Digital
MHH
$92.7M
| $435K | ﹤0.01% |
29,284
-1,000
| -3% | -$17.9K |
|
2269
Sonic Automotive
SAH
$2.56B
| $434K | ﹤0.01% |
11,844
-570
| -5% | -$24.5K |
|
2270
Titan International
TWI
$450M
| $434K | ﹤0.01% |
28,712
-18,542
| -39% | -$299K |
|
2271
E.W. Scripps
SSP
$310M
| $429K | ﹤0.01% |
34,371
+995
| +3% | +$15.9K |
|
|
EGRX
2272
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $428K | ﹤0.01% |
9,644
-3,444
| -26% | -$158K |
|
2273
TG Therapeutics
TGTX
$7.58B
| $426K | ﹤0.01% |
100,257
-480,718
| -83% | -$3M |
|
2274
iShares Biotechnology ETF
IBB
$9.77B
| $425K | ﹤0.01% |
3,614
| – | – |
|
2275
The RMR Group
RMR
$337M
| $425K | ﹤0.01% |
15,007
-5,745
| -28% | -$166K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.